<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">295</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2019-18-4-127-135</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>LITERATURE REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Osteosarcoma with lung metastases</article-title><trans-title-group xml:lang="ru"><trans-title>Метастатическое поражение легких при остеосаркоме</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6922-1077</contrib-id><name-alternatives><name xml:lang="en"><surname>Zhilkin</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Жилкин</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p/><p><bold>Correspondence</bold>: Ilya V. Zhilkin, МD, pediatrician of Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.</p><italic>Address: Russia 117997, Moscow, Samory Mashela st., 1</italic></bio><bio xml:lang="ru"><p/><p><bold>Контактная информация</bold>: Жилкин Илья Владимирович, врач-педиатр, НМИЦ детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России.</p><italic>Адрес: 117997, Москва, ГСП-7, ул. Саморы Машела, 1</italic></bio><email>izhilkin@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1387-209X</contrib-id><name-alternatives><name xml:lang="en"><surname>Akhaladze</surname><given-names>D. G.</given-names></name><name xml:lang="ru"><surname>Ахаладзе</surname><given-names>Д. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7461-0050</contrib-id><name-alternatives><name xml:lang="en"><surname>Litvinov</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Литвинов</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9424-1646</contrib-id><name-alternatives><name xml:lang="en"><surname>Uskova</surname><given-names>N. G.</given-names></name><name xml:lang="ru"><surname>Ускова</surname><given-names>Н. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5679-8961</contrib-id><name-alternatives><name xml:lang="en"><surname>Tihonova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Тихонова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4451-3233</contrib-id><name-alternatives><name xml:lang="en"><surname>Grachev</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Грачев</surname><given-names>Н. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karachunskiy</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Карачунский</surname><given-names>А. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Moscow</italic></p></bio><bio xml:lang="ru"><p><italic>Москва</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-31" publication-format="electronic"><day>31</day><month>12</month><year>2019</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>127</fpage><lpage>135</lpage><history><date date-type="received" iso-8601-date="2019-12-31"><day>31</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-31"><day>31</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/295">https://hemoncim.com/jour/article/view/295</self-uri><abstract xml:lang="en"><p>Osteosarcoma is the bone tumor that most commonly affects children and adolescents. Before the introduction of polychemotherapy &gt; 90% of patients with osteosarcoma died from pulmonary metastases. Despite development of new protocols of therapy in 30–40% of patients the disease is recurrent, more than 80% of them detected pulmonary metastasis. In this review we discussed the problems of detection of metastatic lung lesions and current approaches of methods of detection and marking of small sized metastatic lung lesions. An additional option in the treatment of lung metastases is intraoperative isolated lung perfusion, surgical approaches of which were also discussed.</p></abstract><trans-abstract xml:lang="ru"><p>Остеосаркома относится к наиболее часто встречающимся злокачественным опухолям костей у детей и подростков. До начала применения полихимиотерапии смертность при метастатической болезни при остеосаркоме составляла более 90%. Несмотря на постоянное развитие протоколов терапии и наблюдения, в процессе лечения у 30–40% пациентов заболевание носит рецидивирующий характер, при этом более чем у 80% из них выявляют метастазы в легких. В данном обзоре рассмотрены проблемы диагностики метастатического поражения легких и современные подходы к методам обнаружения и маркировки метастатических очагов легких малых размеров. Дополнительная опция в лечении метастазов легких, недоступных для выявления и хирургической резекции, – интраоперационная изолированная химиоперфузия легкого. Рассмотрены также хирургические подходы к изолированной перфузии легких.</p></trans-abstract><kwd-group xml:lang="en"><kwd>osteosarcoma</kwd><kwd>diagnosis of pulmonary metastases</kwd><kwd>isolated lung perfusion</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеосаркома</kwd><kwd>диагностика легочных метастазов</kwd><kwd>химиоперфузия легких</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Isakoff M.S., Bielack S.S., Meltzer P., Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol 2015 Sep 20; 33 (27): 3029–35.</mixed-citation></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Stiller C.A., Bielack S.S., Jundt G., Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006 Sep; 42 (13): 2124–35.</mixed-citation><mixed-citation xml:lang="ru">Stiller C.A., Bielack S.S., Jundt G., Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006 Sep; 42 (13): 2124–35.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Ries L.А.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995.</mixed-citation><mixed-citation xml:lang="ru">Ries L.А.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Ritter J., Bielack S.S. Osteosarcoma. Ann Oncol 2010 Oct; 21 Suppl 7: vii320–325.</mixed-citation><mixed-citation xml:lang="ru">Ritter J., Bielack S.S. Osteosarcoma. Ann Oncol 2010 Oct; 21 Suppl 7: vii320–325.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Szendroi M., Pápai Z., Koós R., Illés T. Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience. J Surg Oncol 2000 Feb; 73 (2): 87–94.</mixed-citation><mixed-citation xml:lang="ru">Szendroi M., Pápai Z., Koós R., Illés T. Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience. J Surg Oncol 2000 Feb; 73 (2): 87–94.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K., et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002 Feb 1; 20 (3): 776–90.</mixed-citation><mixed-citation xml:lang="ru">Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K., et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002 Feb 1; 20 (3): 776–90.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Kandioler D., Krömer E., Tüchler H., End A., Müller M.R., Wolner E., et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998 Apr; 65 (4): 909–12.</mixed-citation><mixed-citation xml:lang="ru">Kandioler D., Krömer E., Tüchler H., End A., Müller M.R., Wolner E., et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998 Apr; 65 (4): 909–12.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Meyers P.A., Heller G., Healey J.H., Huvos A., Applewhite A., Sun M., et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993 Mar; 11 (3): 449–53.</mixed-citation><mixed-citation xml:lang="ru">Meyers P.A., Heller G., Healey J.H., Huvos A., Applewhite A., Sun M., et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993 Mar; 11 (3): 449–53.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Marina N.M., Smeland S., Bielack S.S., Bernstein M., Jovic G., Krailo M.D., at al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology 2016; 17 (10): 1396–408.</mixed-citation><mixed-citation xml:lang="ru">Marina N.M., Smeland S., Bielack S.S., Bernstein M., Jovic G., Krailo M.D., at al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology 2016; 17 (10): 1396–408.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Kempf-Bielack B., Bielack S.S., Jürgens H., Branscheid D., Berdel W.E., Exner G.U., et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005 Jan 20; 23 (3): 559–68.</mixed-citation><mixed-citation xml:lang="ru">Kempf-Bielack B., Bielack S.S., Jürgens H., Branscheid D., Berdel W.E., Exner G.U., et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005 Jan 20; 23 (3): 559–68.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Aljubran A.H., Griffin A., Pintilie M., Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol 2009 Jun; 20 (6): 1136–41.</mixed-citation><mixed-citation xml:lang="ru">Aljubran A.H., Griffin A., Pintilie M., Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol 2009 Jun; 20 (6): 1136–41.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Gelderblom H., Jinks R.C., Sydes M., Bramwell V.H.C., van Glabbeke M., Grimer R.J., et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 2011 Apr; 47 (6): 895–902.</mixed-citation><mixed-citation xml:lang="ru">Gelderblom H., Jinks R.C., Sydes M., Bramwell V.H.C., van Glabbeke M., Grimer R.J., et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 2011 Apr; 47 (6): 895–902.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Bacci G., Briccoli A., Ferrari S., Longhi A., Mercuri M., Capanna R., et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli’s 4th protocol. Eur J Cancer 2001 Nov; 37 (16): 2030–9.</mixed-citation><mixed-citation xml:lang="ru">Bacci G., Briccoli A., Ferrari S., Longhi A., Mercuri M., Capanna R., et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli’s 4th protocol. Eur J Cancer 2001 Nov; 37 (16): 2030–9.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Petrilli A.S., de Camargo B., Filho V.O., Bruniera P., Brunetto A.L., Jesus-Garcia R., et al. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol 2006 Mar 1; 24(7): 1161–8.</mixed-citation><mixed-citation xml:lang="ru">Petrilli A.S., de Camargo B., Filho V.O., Bruniera P., Brunetto A.L., Jesus-Garcia R., et al. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol 2006 Mar 1; 24(7): 1161–8.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Kager L., Zoubek A., Pötschger U., Kastner U., Flege S., Kempf-Bielack B., et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003 May 15; 21 (10): 2011–8.</mixed-citation><mixed-citation xml:lang="ru">Kager L., Zoubek A., Pötschger U., Kastner U., Flege S., Kempf-Bielack B., et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003 May 15; 21 (10): 2011–8.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Mialou V., Philip T., Kalifa C., Perol D., Gentet J.-C., Marec-Berard P., et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Cancer 2005 Sep 1; 104 (5): 1100–9.</mixed-citation><mixed-citation xml:lang="ru">Mialou V., Philip T., Kalifa C., Perol D., Gentet J.-C., Marec-Berard P., et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Cancer 2005 Sep 1; 104 (5): 1100–9.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Briccoli A., Rocca M., Salone M., Guzzardella G.A., Balladelli A., Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol 2010 Dec; 19 (4): 193–9.</mixed-citation><mixed-citation xml:lang="ru">Briccoli A., Rocca M., Salone M., Guzzardella G.A., Balladelli A., Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol 2010 Dec; 19 (4): 193–9.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Bacci G., Rocca M., Salone M., Balladelli A., Ferrari S., Palmerini E., et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 2008 Nov 1; 98 (6): 415–20.</mixed-citation><mixed-citation xml:lang="ru">Bacci G., Rocca M., Salone M., Balladelli A., Ferrari S., Palmerini E., et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 2008 Nov 1; 98 (6): 415–20.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Harris M.B., Cantor A.B., Goorin A.M., Shochat S.J., Ayala A.G., Ferguson W.S., et al. Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol 1995 Feb; 24 (2): 87–92.</mixed-citation><mixed-citation xml:lang="ru">Harris M.B., Cantor A.B., Goorin A.M., Shochat S.J., Ayala A.G., Ferguson W.S., et al. Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol 1995 Feb; 24 (2): 87–92.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Hawkins D.S., Arndt C.A.S. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.</mixed-citation><mixed-citation xml:lang="ru">Hawkins D.S., Arndt C.A.S. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><mixed-citation>Cancer 2003 Dec 1; 98 (11): 2447–56.</mixed-citation></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">21. Daw N.C., Chou A.J., Jaffe N., Rao B.N., Billups C.A., Rodriguez-Galindo C., et al. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 2015 Jan 20; 112 (2): 278–82.</mixed-citation><mixed-citation xml:lang="ru">Daw N.C., Chou A.J., Jaffe N., Rao B.N., Billups C.A., Rodriguez-Galindo C., et al. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 2015 Jan 20; 112 (2): 278–82.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">22. Briccoli A., Rocca M., Salone M., Bacci G., Ferrari S., Balladelli A., et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005; 104 (8): 1721–5.</mixed-citation><mixed-citation xml:lang="ru">Briccoli A., Rocca M., Salone M., Bacci G., Ferrari S., Balladelli A., et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005; 104 (8): 1721–5.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">23. Bielack S.S., Kempf-Bielack B., Branscheid D., Carrle D., Friedel G., Helmke K., et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009 Feb 1; 27 (4): 557–65.</mixed-citation><mixed-citation xml:lang="ru">Bielack S.S., Kempf-Bielack B., Branscheid D., Carrle D., Friedel G., Helmke K., et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009 Feb 1; 27 (4): 557–65.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">24. Temeck B.K., Wexler L.H., Steinberg S.M., McClure L.L., Horowitz M., Pass H.I. Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg 1995 Jun; 59 (6): 1385–9; discussion 1390.</mixed-citation><mixed-citation xml:lang="ru">Temeck B.K., Wexler L.H., Steinberg S.M., McClure L.L., Horowitz M., Pass H.I. Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg 1995 Jun; 59 (6): 1385–9; discussion 1390.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">25. Iwata S., Yonemoto T., Iizasa T., Niibe Y., Kamoda H., Ishii T. Oligo-Recurrence of Osteosarcoma Patients: Treatment Strategies for Pulmonary Metastases. Ann Surg Oncol 2015 Dec; 22 Suppl 3: S1332–8.</mixed-citation><mixed-citation xml:lang="ru">Iwata S., Yonemoto T., Iizasa T., Niibe Y., Kamoda H., Ishii T. Oligo-Recurrence of Osteosarcoma Patients: Treatment Strategies for Pulmonary Metastases. Ann Surg Oncol 2015 Dec; 22 Suppl 3: S1332–8.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">26. Salah S., Fayoumi S., Alibraheem A., Massad E., Abdel Jalil R., Yaser S., et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg 2013 Aug; 17 (2): 296–302.</mixed-citation><mixed-citation xml:lang="ru">Salah S., Fayoumi S., Alibraheem A., Massad E., Abdel Jalil R., Yaser S., et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg 2013 Aug; 17 (2): 296–302.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">27. Denbo J.W., Zhu L., Srivastava D., Stokes D.C., Srinivasan S., Hudson M.M., et al. Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study. J Am Coll Surg 2014 Aug; 219 (2): 265–71.</mixed-citation><mixed-citation xml:lang="ru">Denbo J.W., Zhu L., Srivastava D., Stokes D.C., Srinivasan S., Hudson M.M., et al. Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study. J Am Coll Surg 2014 Aug; 219 (2): 265–71.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">28. Carter S.R., Grimer R.J., Sneath R.S., Matthews H.R. Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. Thorax 1991 Oct; 46 (10): 727–31.</mixed-citation><mixed-citation xml:lang="ru">Carter S.R., Grimer R.J., Sneath R.S., Matthews H.R. Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. Thorax 1991 Oct; 46 (10): 727–31.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">29. Van Geel A.N., Pastorino U., Jauch K.W., Judson I.R., Van Coevorden F., Buesa J.M., at al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer: Interdisciplinary International Journal of the American Cancer Society 1996; 77 (4): 675–82.</mixed-citation><mixed-citation xml:lang="ru">Van Geel A.N., Pastorino U., Jauch K.W., Judson I.R., Van Coevorden F., Buesa J.M., at al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer: Interdisciplinary International Journal of the American Cancer Society 1996; 77 (4): 675–82.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">30. Harting M.T., Blakely M.L., Jaffe N., Cox C.S., Hayes-Jordan A., Benjamin R.S., et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg 2006 Jan; 41 (1): 194–9.</mixed-citation><mixed-citation xml:lang="ru">Harting M.T., Blakely M.L., Jaffe N., Cox C.S., Hayes-Jordan A., Benjamin R.S., et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg 2006 Jan; 41 (1): 194–9.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">31. Fernandez-Pineda I., Daw N.C., McCarville B., Emanus L.J., Rao B.N., Davidoff A.M., et al. Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a singleinstitution experience. J Pediatr Surg 2012 Jun; 47 (6): 1250–4.</mixed-citation><mixed-citation xml:lang="ru">Fernandez-Pineda I., Daw N.C., McCarville B., Emanus L.J., Rao B.N., Davidoff A.M., et al. Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a singleinstitution experience. J Pediatr Surg 2012 Jun; 47 (6): 1250–4.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">32. Xiao X., Wang W., Wang Z. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatr Drugs 2014 Dec; 16 (6): 503–12.</mixed-citation><mixed-citation xml:lang="ru">Xiao X., Wang W., Wang Z. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatr Drugs 2014 Dec; 16 (6): 503–12.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">33. Yamamoto N., Tsuchiya H. Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going? Expert Opin Pharmacother 2013 Nov; 14 (16): 2183–93.</mixed-citation><mixed-citation xml:lang="ru">Yamamoto N., Tsuchiya H. Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going? Expert Opin Pharmacother 2013 Nov; 14 (16): 2183–93.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">34. Ferrari S., Briccoli A., Mercuri M., Bertoni F., Picci P., Tienghi A., et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol 2003 Feb 15; 21 (4): 710–5.</mixed-citation><mixed-citation xml:lang="ru">Ferrari S., Briccoli A., Mercuri M., Bertoni F., Picci P., Tienghi A., et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol 2003 Feb 15; 21 (4): 710–5.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">35. Crompton B.D., Goldsby R.E., Weinberg V.K., Feren R., O’Donnell R.J., Ablin A.R. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer 2006 Sep; 47 (3): 255–9.</mixed-citation><mixed-citation xml:lang="ru">Crompton B.D., Goldsby R.E., Weinberg V.K., Feren R., O’Donnell R.J., Ablin A.R. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer 2006 Sep; 47 (3): 255–9.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">36. Leary S.E.S., Wozniak A.W., Billups C.A., Wu.J., McPherson V., Neel M.D., et al. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children’s Research Hospital experience. Cancer 2013 Jul 15; 119 (14): 2645–53.</mixed-citation><mixed-citation xml:lang="ru">Leary S.E.S., Wozniak A.W., Billups C.A., Wu.J., McPherson V., Neel M.D., et al. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children’s Research Hospital experience. Cancer 2013 Jul 15; 119 (14): 2645–53.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">37. Tabone M.D., Kalifa C., Rodary C., Raquin M., Valteau-Couanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. Journal of Clinical Oncology 1994; 12 (12): 2614–20.</mixed-citation><mixed-citation xml:lang="ru">Tabone M.D., Kalifa C., Rodary C., Raquin M., Valteau-Couanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. Journal of Clinical Oncology 1994; 12 (12): 2614–20.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">38. Seo J.B., Im J.G., Goo J.M., Chung M.J., Kim M.Y. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 2001; 21 (2): 403–17.</mixed-citation><mixed-citation xml:lang="ru">Seo J.B., Im J.G., Goo J.M., Chung M.J., Kim M.Y. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 2001; 21 (2): 403–17.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">39. Iagaru A., Chawla S., Menendez L., Conti P.S. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nuclear Medicine Communications 2006 Oct; 27 (10): 795.</mixed-citation><mixed-citation xml:lang="ru">Iagaru A., Chawla S., Menendez L., Conti P.S. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nuclear Medicine Communications 2006 Oct; 27 (10): 795.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">40. Franzius C., Daldrup-Link H.E., Sciuk J., Rummeny E.J., Bielack S., Jürgens H., et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001 Apr; 12 (4): 479–86.</mixed-citation><mixed-citation xml:lang="ru">Franzius C., Daldrup-Link H.E., Sciuk J., Rummeny E.J., Bielack S., Jürgens H., et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001 Apr; 12 (4): 479–86.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">41. Reinhardt M.J., Wiethoelter N., Matthies A., Joe A.Y., Strunk H., Jaeger U., at al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. European journal of nuclear medicine and molecular imaging 2006; 33 (2): 134–9.</mixed-citation><mixed-citation xml:lang="ru">Reinhardt M.J., Wiethoelter N., Matthies A., Joe A.Y., Strunk H., Jaeger U., at al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. European journal of nuclear medicine and molecular imaging 2006; 33 (2): 134–9.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">42. Liu F., Zhang Q., Zhu D., Li Z., Li J., Wang B., et al. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015 Sep; 94 (36): e1462.</mixed-citation><mixed-citation xml:lang="ru">Liu F., Zhang Q., Zhu D., Li Z., Li J., Wang B., et al. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015 Sep; 94 (36): e1462.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">43. Ferguson W.S., Goorin A.M. Current treatment of osteosarcoma. Cancer Invest 2001; 19 (3): 292–315.</mixed-citation><mixed-citation xml:lang="ru">Ferguson W.S., Goorin A.M. Current treatment of osteosarcoma. Cancer Invest 2001; 19 (3): 292–315.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">44. Jeffree G.M., Price C.H., Sissons H.A. The metastatic patterns of osteosarcoma. Br J Cancer 1975 Jul; 32 (1): 87–107.</mixed-citation><mixed-citation xml:lang="ru">Jeffree G.M., Price C.H., Sissons H.A. The metastatic patterns of osteosarcoma. Br J Cancer 1975 Jul; 32 (1): 87–107.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">45. Meyer J.S., Nadel H.R., Marina N., Womer R.B., Brown K.L.B., Eary J.F., et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 2008 Aug; 51 (2): 163–70.</mixed-citation><mixed-citation xml:lang="ru">Meyer J.S., Nadel H.R., Marina N., Womer R.B., Brown K.L.B., Eary J.F., et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 2008 Aug; 51 (2): 163–70.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">46. Kayton M.L., Huvos A.G., Casher J., Abramson S.J., Rosen N.S., Wexler L.H., et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 2006 Jan; 41 (1): 200–6; discussion 200–6.</mixed-citation><mixed-citation xml:lang="ru">Kayton M.L., Huvos A.G., Casher J., Abramson S.J., Rosen N.S., Wexler L.H., et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 2006 Jan; 41 (1): 200–6; discussion 200–6.</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">47. McCormack P.M., Bains M.S., Begg C.B., Burt M.E., Downey R.J., Panicek D.M., et al. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 1996 Jul; 62 (1): 213–6; discussion 216–7.</mixed-citation><mixed-citation xml:lang="ru">McCormack P.M., Bains M.S., Begg C.B., Burt M.E., Downey R.J., Panicek D.M., et al. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 1996 Jul; 62 (1): 213–6; discussion 216–7.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">48. Yim A.P., Lin J., Chan A.T., Li C.K., Ho J.K. Video-assisted thoracoscopic wedge resections of pulmonary metastatic osteosarcoma: should it be performed? Aust N Z J Surg 1995 Oct; 65 (10): 737–9.</mixed-citation><mixed-citation xml:lang="ru">Yim A.P., Lin J., Chan A.T., Li C.K., Ho J.K. Video-assisted thoracoscopic wedge resections of pulmonary metastatic osteosarcoma: should it be performed? Aust N Z J Surg 1995 Oct; 65 (10): 737–9.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">49. Fuchs J., Seitz G., Handgretinger R., Schäfer J., Warmann S.W. Surgical treatment of lung metastases in patients with embryonal pediatric solid tumors: an update. Seminars in Pediatric Surgery 2012 Feb 1; 21 (1): 79–87.</mixed-citation><mixed-citation xml:lang="ru">Fuchs J., Seitz G., Handgretinger R., Schäfer J., Warmann S.W. Surgical treatment of lung metastases in patients with embryonal pediatric solid tumors: an update. Seminars in Pediatric Surgery 2012 Feb 1; 21 (1): 79–87.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">50. Picci P., Vanel D., Briccoli A., Talle K., Haakenaasen U., Malaguti C., et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001 Nov; 12 (11): 1601–4.</mixed-citation><mixed-citation xml:lang="ru">Picci P., Vanel D., Briccoli A., Talle K., Haakenaasen U., Malaguti C., et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001 Nov; 12 (11): 1601–4.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">51. Wicky S., Dusmet M., Doenz F., Ris H.B., Schnyder P., Portier F. Computed tomography–guided localization of small lung nodules before video-assisted resection: Experience with an efficient hook-wire system. The Journal of Thoracic and Cardiovascular Surgery 2002 Aug 1; 124 (2): 401–3.</mixed-citation><mixed-citation xml:lang="ru">Wicky S., Dusmet M., Doenz F., Ris H.B., Schnyder P., Portier F. Computed tomography–guided localization of small lung nodules before video-assisted resection: Experience with an efficient hook-wire system. The Journal of Thoracic and Cardiovascular Surgery 2002 Aug 1; 124 (2): 401–3.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">52. Dendo S., Kanazawa S., Ando A., Hyodo T., Kouno Y., Yasui K., et al. Preoperative Localization of Small Pulmonary Lesions with a Short Hook Wire and Suture System: Experience with 168 Procedures. Radiology 2002 Nov 1; 225 (2): 511–8.</mixed-citation><mixed-citation xml:lang="ru">Dendo S., Kanazawa S., Ando A., Hyodo T., Kouno Y., Yasui K., et al. Preoperative Localization of Small Pulmonary Lesions with a Short Hook Wire and Suture System: Experience with 168 Procedures. Radiology 2002 Nov 1; 225 (2): 511–8.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">53. Plunkett M.B., Peterson M.S., Landreneau R.J., Ferson P.F., Posner M.C. Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology 1992 Oct 1; 185 (1): 274–6.</mixed-citation><mixed-citation xml:lang="ru">Plunkett M.B., Peterson M.S., Landreneau R.J., Ferson P.F., Posner M.C. Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology 1992 Oct 1; 185 (1): 274–6.</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">54. Sortini D., Feo C.V., Carcoforo P., Carrella G., Pozza E., Liboni A., et al. Thoracoscopic Localization Techniques for Patients With Solitary Pulmonary Nodule and History of Malignancy. The Annals of Thoracic Surgery 2005 Jan 1; 79 (1): 258–62.</mixed-citation><mixed-citation xml:lang="ru">Sortini D., Feo C.V., Carcoforo P., Carrella G., Pozza E., Liboni A., et al. Thoracoscopic Localization Techniques for Patients With Solitary Pulmonary Nodule and History of Malignancy. The Annals of Thoracic Surgery 2005 Jan 1; 79 (1): 258–62.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">55. Shennib H., Bret P. Intraoperative transthoracic ultrasonographic localization of occult lung lesions. The Annals of Thoracic Surgery 1993 Mar 1; 55 (3): 767–9.</mixed-citation><mixed-citation xml:lang="ru">Shennib H., Bret P. Intraoperative transthoracic ultrasonographic localization of occult lung lesions. The Annals of Thoracic Surgery 1993 Mar 1; 55 (3): 767–9.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">56. Asano F., Shindoh J., Shigemitsu K., Miya K., Abe T., Horiba M., et al. Ultrathin Bronchoscopic Barium Marking With Virtual Bronchoscopic Navigation for Fluoroscopy-Assisted Thoracoscopic Surgery. Chest 2004 Nov 1; 126 (5): 1687–93.</mixed-citation><mixed-citation xml:lang="ru">Asano F., Shindoh J., Shigemitsu K., Miya K., Abe T., Horiba M., et al. Ultrathin Bronchoscopic Barium Marking With Virtual Bronchoscopic Navigation for Fluoroscopy-Assisted Thoracoscopic Surgery. Chest 2004 Nov 1; 126 (5): 1687–93.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">57. Okumura T., Kondo H., Suzuki K., Asamura H., Kobayashi T., Kaneko M., et al. Fluoroscopy-assisted thoracoscopic surgery after computed tomography-guided bronchoscopic barium marking. The Annals of Thoracic Surgery 2001 Feb 1; 71 (2): 439–42.</mixed-citation><mixed-citation xml:lang="ru">Okumura T., Kondo H., Suzuki K., Asamura H., Kobayashi T., Kaneko M., et al. Fluoroscopy-assisted thoracoscopic surgery after computed tomography-guided bronchoscopic barium marking. The Annals of Thoracic Surgery 2001 Feb 1; 71 (2): 439–42.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">58. Endo M., Kotani Y., Satouchi M., Takada Y., Sakamoto T., Tsubota N., et al. CT Fluoroscopy-Guided Bronchoscopic Dye Marking for Resection of Small Peripheral Pulmonary Nodules. Chest 2004 May 1; 125 (5): 1747–52.</mixed-citation><mixed-citation xml:lang="ru">Endo M., Kotani Y., Satouchi M., Takada Y., Sakamoto T., Tsubota N., et al. CT Fluoroscopy-Guided Bronchoscopic Dye Marking for Resection of Small Peripheral Pulmonary Nodules. Chest 2004 May 1; 125 (5): 1747–52.</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">59. Kerrigan D.C., Spence P.A., Crittenden M.D., Tripp M.D. Methylene blue guidance for simplified resection of a lung lesion. The Annals of Thoracic Surgery 1992 Jan 1; 53 (1): 163–4.</mixed-citation><mixed-citation xml:lang="ru">Kerrigan D.C., Spence P.A., Crittenden M.D., Tripp M.D. Methylene blue guidance for simplified resection of a lung lesion. The Annals of Thoracic Surgery 1992 Jan 1; 53 (1): 163–4.</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">60. Nomori H., Horio H. Colored collagen is a long-lasting point marker for small pulmonary nodules in thoracoscopic operations. The Annals of Thoracic Surgery 1996 Apr 1; 61 (4): 1070–3.</mixed-citation><mixed-citation xml:lang="ru">Nomori H., Horio H. Colored collagen is a long-lasting point marker for small pulmonary nodules in thoracoscopic operations. The Annals of Thoracic Surgery 1996 Apr 1; 61 (4): 1070–3.</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">61. Moon S.-W., Wang Y.-P., Jo K.-H., Kwack M.-S., Kim S.-W., Kwon O.-K., et al. Fluoroscopy-aided thoracoscopic resection of pulmonary nodule localized with contrast media. The Annals of Thoracic Surgery 1999 Nov 1; 68 (5): 1815–20.</mixed-citation><mixed-citation xml:lang="ru">Moon S.-W., Wang Y.-P., Jo K.-H., Kwack M.-S., Kim S.-W., Kwon O.-K., et al. Fluoroscopy-aided thoracoscopic resection of pulmonary nodule localized with contrast media. The Annals of Thoracic Surgery 1999 Nov 1; 68 (5): 1815–20.</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">62. Nomori H., Horio H., Naruke T., Suemasu K. Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol. The Annals of Thoracic Surgery 2002 Jul 1; 74 (1): 170–3.</mixed-citation><mixed-citation xml:lang="ru">Nomori H., Horio H., Naruke T., Suemasu K. Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol. The Annals of Thoracic Surgery 2002 Jul 1; 74 (1): 170–3.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">63. Watanabe K., Nomori H., Ohtsuka T., Kaji M., Naruke T., Suemasu K. Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: Experience with 174 nodules. The Journal of Thoracic and Cardiovascular Surgery 2006 Aug 1; 132 (2): 320–4.</mixed-citation><mixed-citation xml:lang="ru">Watanabe K., Nomori H., Ohtsuka T., Kaji M., Naruke T., Suemasu K. Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: Experience with 174 nodules. The Journal of Thoracic and Cardiovascular Surgery 2006 Aug 1; 132 (2): 320–4.</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">64. Tsuchida M., Yamato Y., Aoki T., Watanabe T., Koizumi N., Emura I., et al. CT-Gui-ded Agar Marking for Localization of Nonpalpable Peripheral Pulmonary Lesions. Chest 1999 Jul 1; 116 (1): 139–43.</mixed-citation><mixed-citation xml:lang="ru">Tsuchida M., Yamato Y., Aoki T., Watanabe T., Koizumi N., Emura I., et al. CT-Gui-ded Agar Marking for Localization of Nonpalpable Peripheral Pulmonary Lesions. Chest 1999 Jul 1; 116 (1): 139–43.</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">65. Iwasaki Y., Nagata K., Yuba T., Hosogi S., Kohno K., Ohsugi S., at al. Fluoroscopy-guided barium marking for localizing small pulmonary lesions before video-assisted thoracic surgery. Respiratory medicine 2005; 99 (3); 285–9.</mixed-citation><mixed-citation xml:lang="ru">Iwasaki Y., Nagata K., Yuba T., Hosogi S., Kohno K., Ohsugi S., at al. Fluoroscopy-guided barium marking for localizing small pulmonary lesions before video-assisted thoracic surgery. Respiratory medicine 2005; 99 (3); 285–9.</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">66. Gaffke G., Stroszczynski C., Rau B., Liebeskind U., Hünerbein M., Bayraktar S., et al. [CT-guided resection of pulmonary metastases]. Rofo 2005 Jun; 177 (6): 877–83.</mixed-citation><mixed-citation xml:lang="ru">Gaffke G., Stroszczynski C., Rau B., Liebeskind U., Hünerbein M., Bayraktar S., et al. [CT-guided resection of pulmonary metastases]. Rofo 2005 Jun; 177 (6): 877–83.</mixed-citation></citation-alternatives></ref><ref id="B68"><label>68.</label><citation-alternatives><mixed-citation xml:lang="en">67. Kamiyoshihara M., Sakata K., Ishikawa S., Morishita Y. Cerebral arterial air embolism following CT-guided lung needle marking: report of a case. Journal of Cardiovascular Surgery 2001; 42 (5): 699.</mixed-citation><mixed-citation xml:lang="ru">Kamiyoshihara M., Sakata K., Ishikawa S., Morishita Y. Cerebral arterial air embolism following CT-guided lung needle marking: report of a case. Journal of Cardiovascular Surgery 2001; 42 (5): 699.</mixed-citation></citation-alternatives></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">68. Horan T.A., Pinheiro P.M., Araújo L.M., Santiago F.F., Rodrigues M.R. Massive gas embolism during pulmonary nodule hook wire localization. The Annals of thoracic surgery 2002; 73 (5): 1647–9.</mixed-citation><mixed-citation xml:lang="ru">Horan T.A., Pinheiro P.M., Araújo L.M., Santiago F.F., Rodrigues M.R. Massive gas embolism during pulmonary nodule hook wire localization. The Annals of thoracic surgery 2002; 73 (5): 1647–9.</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><citation-alternatives><mixed-citation xml:lang="en">69. Sakiyama S., Kondo K., Matsuoka H., Yoshida M., Miyoshi T., Yoshida S., et al. Fatal air embolism during computed tomography–guided pulmonary marking with a hook-type marker. The Journal of Thoracic and Cardiovascular Surgery 2003 Oct 1; 126 (4): 1207–9.</mixed-citation><mixed-citation xml:lang="ru">Sakiyama S., Kondo K., Matsuoka H., Yoshida M., Miyoshi T., Yoshida S., et al. Fatal air embolism during computed tomography–guided pulmonary marking with a hook-type marker. The Journal of Thoracic and Cardiovascular Surgery 2003 Oct 1; 126 (4): 1207–9.</mixed-citation></citation-alternatives></ref><ref id="B71"><label>71.</label><citation-alternatives><mixed-citation xml:lang="en">70. Sato K., Miyauchi K., Shikata F., Murakami T., Yoshioka S., Kawachi K. Arterial air embolism during percutaneous pulmonary marking under computed tomography guidance. Jpn J Thorac Caridovasc Surg 2005 Jul 1; 53 (7): 404–6.</mixed-citation><mixed-citation xml:lang="ru">Sato K., Miyauchi K., Shikata F., Murakami T., Yoshioka S., Kawachi K. Arterial air embolism during percutaneous pulmonary marking under computed tomography guidance. Jpn J Thorac Caridovasc Surg 2005 Jul 1; 53 (7): 404–6.</mixed-citation></citation-alternatives></ref><ref id="B72"><label>72.</label><citation-alternatives><mixed-citation xml:lang="en">71. Creech O., Krementz E., Ryan R., Winblad J. Chemotherapy of Cancer. Annals of Surgery 1958 Oct 1; 148 (4): 616–32.</mixed-citation><mixed-citation xml:lang="ru">Creech O., Krementz E., Ryan R., Winblad J. Chemotherapy of Cancer. Annals of Surgery 1958 Oct 1; 148 (4): 616–32.</mixed-citation></citation-alternatives></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">72. Ranney D.F. Drug targeting to the lungs. Biochemical Pharmacology 1986 Apr 1; 35 (7): 1063–9.</mixed-citation><mixed-citation xml:lang="ru">Ranney D.F. Drug targeting to the lungs. Biochemical Pharmacology 1986 Apr 1; 35 (7): 1063–9.</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">73. Nawata S., Abecasis N., Ross H.M., Abolhoda A., Cheng H., Sachar K.S., et al. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. The Journal of Thoracic and Cardiovascular Surgery 1996 Dec 1; 112 (6): 1542–8.</mixed-citation><mixed-citation xml:lang="ru">Nawata S., Abecasis N., Ross H.M., Abolhoda A., Cheng H., Sachar K.S., et al. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. The Journal of Thoracic and Cardiovascular Surgery 1996 Dec 1; 112 (6): 1542–8.</mixed-citation></citation-alternatives></ref><ref id="B75"><label>75.</label><citation-alternatives><mixed-citation xml:lang="en">74. Hendriks J.M.H., Van Schil P.E.Y. Isolated lung perfusion for the treatment of pulmonary metastases. Surgical Oncology 1998 Jul 1; 7 (1): 59–63.</mixed-citation><mixed-citation xml:lang="ru">Hendriks J.M.H., Van Schil P.E.Y. Isolated lung perfusion for the treatment of pulmonary metastases. Surgical Oncology 1998 Jul 1; 7 (1): 59–63.</mixed-citation></citation-alternatives></ref><ref id="B76"><label>76.</label><citation-alternatives><mixed-citation xml:lang="en">75. Левченко Е.В., Гумбатова Э.Д., Кулева С.А., Сенчик К.Ю., Мамонтов О.Ю., Калинин П.С. и др. Изолированная химиоперфузия легкого и плевры как метод лечения у детей с распространенными формами солидных опухолей костей. Российский журнал детской гематологии и онкологии 2019; 1. https://cyberleninka.ru/article/n/izolirovannaya-himioperfuziya-legkogoiplevry-kak-metod-lecheniya-u-detey-s-rasprostranennymi-formami-solidnyh-opuholey-kostey</mixed-citation><mixed-citation xml:lang="ru">Левченко Е.В., Гумбатова Э.Д., Кулева С.А., Сенчик К.Ю., Мамонтов О.Ю., Калинин П.С. и др. Изолированная химиоперфузия легкого и плевры как метод лечения у детей с распространенными формами солидных опухолей костей. Российский журнал детской гематологии и онкологии 2019; 1. https://cyberleninka.ru/article/n/izolirovannaya-himioperfuziya-legkogoiplevry-kak-metod-lecheniya-u-detey-s-rasprostranennymi-formami-solidnyh-opuholey-kostey</mixed-citation></citation-alternatives></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">76. Гумбатова Э.Д. Метастатическое поражение легких у детей с солидными опухолями: исторический экскурс.оссийский журнал детской гематологии и онкологии 2019; 1. https://cyberleninka.ru/article/n/izolirovannaya-himioperfuziya-legkogo-i-plevry-kak-metod-lecheniya-u-detey-s-rasprostranennymi-formami-solidnyh-opuholey-kostey</mixed-citation><mixed-citation xml:lang="ru">Гумбатова Э.Д. Метастатическое поражение легких у детей с солидными опухолями: исторический экскурс.оссийский журнал детской гематологии и онкологии 2019; 1. https://cyberleninka.ru/article/n/izolirovannaya-himioperfuziya-legkogo-i-plevry-kak-metod-lecheniya-u-detey-s-rasprostranennymi-formami-solidnyh-opuholey-kostey</mixed-citation></citation-alternatives></ref><ref id="B78"><label>78.</label><citation-alternatives><mixed-citation xml:lang="en">77. Левченко Е.В., Калинин П.С., Сенчик К.Ю., Чжан Вэнь, Ван Тин, Мамонтов О.Ю. и др. Обоснование модели расчета индивидуальной дозы цитостатиков с использованием КТ-волюметрии для изолированной химиоперфузии легкого с метастазэктомией. Вопросы онкологии 2018; 64 (3): 319–23.</mixed-citation><mixed-citation xml:lang="ru">Левченко Е.В., Калинин П.С., Сенчик К.Ю., Чжан Вэнь, Ван Тин, Мамонтов О.Ю. и др. Обоснование модели расчета индивидуальной дозы цитостатиков с использованием КТ-волюметрии для изолированной химиоперфузии легкого с метастазэктомией. Вопросы онкологии 2018; 64 (3): 319–23.</mixed-citation></citation-alternatives></ref><ref id="B79"><label>79.</label><citation-alternatives><mixed-citation xml:lang="en">78. Hendriks J.M.H., Grootenboers M.J.J.H., Schramel F.M.N.H., van Boven W.J., Stockman B., Seldenrijk C.A., et al. Isolated Lung Perfusion With Melphalan for Resectable Lung Metastases: A Phase I Clinical Trial. The Annals of Thoracic Surgery 2004 Dec 1; 78 (6): 1919–27.</mixed-citation><mixed-citation xml:lang="ru">Hendriks J.M.H., Grootenboers M.J.J.H., Schramel F.M.N.H., van Boven W.J., Stockman B., Seldenrijk C.A., et al. Isolated Lung Perfusion With Melphalan for Resectable Lung Metastases: A Phase I Clinical Trial. The Annals of Thoracic Surgery 2004 Dec 1; 78 (6): 1919–27.</mixed-citation></citation-alternatives></ref><ref id="B80"><label>80.</label><citation-alternatives><mixed-citation xml:lang="en">79. Grootenboers M.J.J.H., Schramel F.M.N.H., van Boven W.J., van Putte B.P., Hendriks J.M.H., Van Schil P.E.Y. Re-Evaluation of Toxicity and Long-Term Follow-Up of Isolated Lung Perfusion With Melphalan in Patients With Resectable Pulmonary Metastases: A Phase I and Extension Trial. Annals of Thoracic Surgery 2007; 83 (3): 1235–6.</mixed-citation><mixed-citation xml:lang="ru">Grootenboers M.J.J.H., Schramel F.M.N.H., van Boven W.J., van Putte B.P., Hendriks J.M.H., Van Schil P.E.Y. Re-Evaluation of Toxicity and Long-Term Follow-Up of Isolated Lung Perfusion With Melphalan in Patients With Resectable Pulmonary Metastases: A Phase I and Extension Trial. Annals of Thoracic Surgery 2007; 83 (3): 1235–6.</mixed-citation></citation-alternatives></ref><ref id="B81"><label>81.</label><citation-alternatives><mixed-citation xml:lang="en">80. Den Hengst W.A., Van Putte B.P., Hendriks J.M.H., Stockman B., van Boven W.-J.P., Weyler J., et al. Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases. European Journal of Cardio-thoracic Surgery 2010; 38 (5): 621–7.</mixed-citation><mixed-citation xml:lang="ru">Den Hengst W.A., Van Putte B.P., Hendriks J.M.H., Stockman B., van Boven W.-J.P., Weyler J., et al. Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases. European Journal of Cardio-thoracic Surgery 2010; 38 (5): 621–7.</mixed-citation></citation-alternatives></ref><ref id="B82"><label>82.</label><citation-alternatives><mixed-citation xml:lang="en">81. den Hengst W.A., Hendriks J.M.H., Balduyck B., Rodrigus I., Vermorken J.B., Lardon F., et al. Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases. Journal of Thoracic Oncology 2014 Oct 1; 9 (10): 1547–53.</mixed-citation><mixed-citation xml:lang="ru">den Hengst W.A., Hendriks J.M.H., Balduyck B., Rodrigus I., Vermorken J.B., Lardon F., et al. Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases. Journal of Thoracic Oncology 2014 Oct 1; 9 (10): 1547–53.</mixed-citation></citation-alternatives></ref><ref id="B83"><label>83.</label><citation-alternatives><mixed-citation xml:lang="en">82. Kümmerle A., Krueger T., Dusmet M., Vallet C., Pan Y., Ris H.B., et al. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. Journal of Pharmaceutical and Biomedical Analysis 2003 Oct 15; 33 (3): 475–94.</mixed-citation><mixed-citation xml:lang="ru">Kümmerle A., Krueger T., Dusmet M., Vallet C., Pan Y., Ris H.B., et al. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. Journal of Pharmaceutical and Biomedical Analysis 2003 Oct 15; 33 (3): 475–94.</mixed-citation></citation-alternatives></ref><ref id="B84"><label>84.</label><citation-alternatives><mixed-citation xml:lang="en">83. Schrump D.S., Zhai S., Nguyen D.M., Weiser T.S., Fisher B.A., Terrill R.E., et al. Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques. The Journal of Thoracic and Cardiovascular Surgery 2002 Apr 1; 123 (4): 686–94.</mixed-citation><mixed-citation xml:lang="ru">Schrump D.S., Zhai S., Nguyen D.M., Weiser T.S., Fisher B.A., Terrill R.E., et al. Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques. The Journal of Thoracic and Cardiovascular Surgery 2002 Apr 1; 123 (4): 686–94.</mixed-citation></citation-alternatives></ref><ref id="B85"><label>85.</label><citation-alternatives><mixed-citation xml:lang="en">84. Schröder C., Fisher S., Pieck A.C., Müller A., Jaehde U., Kirchner H., et al. Technique and results of hyperthermic (41 °C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis. European Journal of Cardiothoracic Surgery 2002; 22 (1): 41–6.</mixed-citation><mixed-citation xml:lang="ru">Schröder C., Fisher S., Pieck A.C., Müller A., Jaehde U., Kirchner H., et al. Technique and results of hyperthermic (41 °C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis. European Journal of Cardiothoracic Surgery 2002; 22 (1): 41–6.</mixed-citation></citation-alternatives></ref><ref id="B86"><label>86.</label><citation-alternatives><mixed-citation xml:lang="en">85. Burt M.E., Liu D., Abolhoda A., Ross H.M., Kaneda Y., Jara E., et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. The Annals of Thoracic Surgery 2000 May 1; 69 (5): 1542–9.</mixed-citation><mixed-citation xml:lang="ru">Burt M.E., Liu D., Abolhoda A., Ross H.M., Kaneda Y., Jara E., et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. The Annals of Thoracic Surgery 2000 May 1; 69 (5): 1542–9.</mixed-citation></citation-alternatives></ref><ref id="B87"><label>87.</label><citation-alternatives><mixed-citation xml:lang="en">86. Ratto G.B., Toma S., Civalleri D., Passerone G.C., Esposito M., Zaccheo D., et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. The Journal of Thoracic and Cardiovascular Surgery 1996 Sep 1; 112 (3): 614–22.</mixed-citation><mixed-citation xml:lang="ru">Ratto G.B., Toma S., Civalleri D., Passerone G.C., Esposito M., Zaccheo D., et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. The Journal of Thoracic and Cardiovascular Surgery 1996 Sep 1; 112 (3): 614–22.</mixed-citation></citation-alternatives></ref><ref id="B88"><label>88.</label><citation-alternatives><mixed-citation xml:lang="en">87. Pass H.I., Mew D.J.Y., Kranda K.C., Temeck B.K., Donington J.S., Rosenberg S.A. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. The Annals of Thoracic Surgery 1996 Jun 1; 61 (6): 1609–17.</mixed-citation><mixed-citation xml:lang="ru">Pass H.I., Mew D.J.Y., Kranda K.C., Temeck B.K., Donington J.S., Rosenberg S.A. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. The Annals of Thoracic Surgery 1996 Jun 1; 61 (6): 1609–17.</mixed-citation></citation-alternatives></ref><ref id="B89"><label>89.</label><citation-alternatives><mixed-citation xml:lang="en">88. Hendriks J.M.H., Van Putte B.P., Grootenboers M., Van Boven W.J., Schramel F., Van Schil P.E.Y. Isolated Lung Perfusion for Pulmonary Metastases. Thoracic Surgery Clinics 2006 May 1; 16 (2): 185–98.</mixed-citation><mixed-citation xml:lang="ru">Hendriks J.M.H., Van Putte B.P., Grootenboers M., Van Boven W.J., Schramel F., Van Schil P.E.Y. Isolated Lung Perfusion for Pulmonary Metastases. Thoracic Surgery Clinics 2006 May 1; 16 (2): 185–98.</mixed-citation></citation-alternatives></ref><ref id="B90"><label>90.</label><citation-alternatives><mixed-citation xml:lang="en">89. Furrer M., Lardinois D., Thormann W., Altermatt H.-J., Betticher D., Triller J., et al. Cytostatic Lung Perfusion by Use of an Endovascular Blood Flow Occlusion Technique. The Annals of Thoracic Surgery 1998 Jun 1; 65 (6): 1523–8.</mixed-citation><mixed-citation xml:lang="ru">Furrer M., Lardinois D., Thormann W., Altermatt H.-J., Betticher D., Triller J., et al. Cytostatic Lung Perfusion by Use of an Endovascular Blood Flow Occlusion Technique. The Annals of Thoracic Surgery 1998 Jun 1; 65 (6): 1523–8.</mixed-citation></citation-alternatives></ref><ref id="B91"><label>91.</label><citation-alternatives><mixed-citation xml:lang="en">90. Van Putte B.P., Hendriks J.M., Romijn S., Pauwels B., De Boeck G., Guetens G., еt al. Pharmacokinetics after pulmonary artery perfusion with gemcitabine. The Annals of thoracic surgery 2003; 76 (4): 1036–40.</mixed-citation><mixed-citation xml:lang="ru">Van Putte B.P., Hendriks J.M., Romijn S., Pauwels B., De Boeck G., Guetens G., еt al. Pharmacokinetics after pulmonary artery perfusion with gemcitabine. The Annals of thoracic surgery 2003; 76 (4): 1036–40.</mixed-citation></citation-alternatives></ref><ref id="B92"><label>92.</label><citation-alternatives><mixed-citation xml:lang="en">91. Kümmerle A., Krueger T., Dusmet M., Vallet C., Pan Y., Ris H.B., et al. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. Journal of Pharmaceutical and Biomedical Analysis 2003 Oct 15; 33 (3): 475–94.</mixed-citation><mixed-citation xml:lang="ru">Kümmerle A., Krueger T., Dusmet M., Vallet C., Pan Y., Ris H.B., et al. A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. Journal of Pharmaceutical and Biomedical Analysis 2003 Oct 15; 33 (3): 475–94.</mixed-citation></citation-alternatives></ref><ref id="B93"><label>93.</label><citation-alternatives><mixed-citation xml:lang="en">92. Jinbo M., Ueda K., Kaneda Y., Sudo M., Li T.-S., Hamano K. Video-assisted transcatheter lung perfusion regional chemotherapy. Eur J Cardiothorac Surg 2005 Jun 1; 27 (6): 1079–82.</mixed-citation><mixed-citation xml:lang="ru">Jinbo M., Ueda K., Kaneda Y., Sudo M., Li T.-S., Hamano K. Video-assisted transcatheter lung perfusion regional chemotherapy. Eur J Cardiothorac Surg 2005 Jun 1; 27 (6): 1079–82.</mixed-citation></citation-alternatives></ref><ref id="B94"><label>94.</label><citation-alternatives><mixed-citation xml:lang="en">93. Franke U.F.W., Wittwer T., Kaluza M., Albert M., Becker V., Roskos M., et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue. Eur J Cardiothorac Surg 2004 Oct 1; 26 (4): 800–6.</mixed-citation><mixed-citation xml:lang="ru">Franke U.F.W., Wittwer T., Kaluza M., Albert M., Becker V., Roskos M., et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue. Eur J Cardiothorac Surg 2004 Oct 1; 26 (4): 800–6.</mixed-citation></citation-alternatives></ref><ref id="B95"><label>95.</label><citation-alternatives><mixed-citation xml:lang="en">94. Franke U.F.W., Wittwer T., Lessel M., Liebing K., Albert M., Becker V., et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity. Eur J Cardiothorac Surg 2004 Oct 1; 26 (4): 792–9.</mixed-citation><mixed-citation xml:lang="ru">Franke U.F.W., Wittwer T., Lessel M., Liebing K., Albert M., Becker V., et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity. Eur J Cardiothorac Surg 2004 Oct 1; 26 (4): 792–9.</mixed-citation></citation-alternatives></ref><ref id="B96"><label>96.</label><citation-alternatives><mixed-citation xml:lang="en">95. Vogl T.J., Lehnert T., Zangos S., Eichler K., Hammerstingl R., Korkusuz H., et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol 2008 Nov 1; 18 (11): 2449–55.</mixed-citation><mixed-citation xml:lang="ru">Vogl T.J., Lehnert T., Zangos S., Eichler K., Hammerstingl R., Korkusuz H., et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol 2008 Nov 1; 18 (11): 2449–55.</mixed-citation></citation-alternatives></ref><ref id="B97"><label>97.</label><citation-alternatives><mixed-citation xml:lang="en">96. Vogl T.J., Wetter A., Lindemayr S., Zangos S. Treatment of Unresectable Lung Metastases with Transpulmonary Chemoembolization: Preliminary Experience. Radiology 2005 Mar 1; 234 (3): 917–22.</mixed-citation><mixed-citation xml:lang="ru">Vogl T.J., Wetter A., Lindemayr S., Zangos S. Treatment of Unresectable Lung Metastases with Transpulmonary Chemoembolization: Preliminary Experience. Radiology 2005 Mar 1; 234 (3): 917–22.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
